Patents Assigned to TAEJOON PHARMACEUTICAL CO., LTD.
  • Publication number: 20240075060
    Abstract: The present invention relates to an oral solid formulation for colon cleansing, wherein the oral solid formulation minimizes side effects, has excellent dosing convenience and medication compliance, enables a pharmaceutical effect to be exhibited quickly, and has excellent colon cleansing ability.
    Type: Application
    Filed: December 30, 2021
    Publication date: March 7, 2024
    Applicant: TAEJOON PHARMACEUTICAL CO., LTD.
    Inventors: Joon Youb LEE, Wan GU, Woo Young JANG, Young Un KIM, Yong Jun KIM
  • Publication number: 20240041974
    Abstract: The present invention relates to a nanoemulsion ophthalmic composition and a preparation method thereof, wherein the nanoemulsion ophthalmic composition is obtained by mixing cyclosporine, castor oil, hydrophilic and hydrophobic emulsifiers, menthol, and an aqueous solvent, and thus exhibits excellent stability as well as ameliorating ocular irritation such as a feeling of grittiness, blurry vision, and the like.
    Type: Application
    Filed: September 4, 2020
    Publication date: February 8, 2024
    Applicant: TAEJOON PHARMACEUTICAL CO., LTD.
    Inventors: Joon Youb LEE, Youn Jae SHIN, Hyun Won SEO, Dae Hun KIM
  • Publication number: 20210052510
    Abstract: The present invention relates to a bowel cleansing composition comprising polyethylene glycol and ascorbate ingredients, the bowel cleansing composition of the present invention being easier to take, while having an excellent bowel cleansing effect, thereby being usable as an effective bowel cleansing agent.
    Type: Application
    Filed: February 1, 2019
    Publication date: February 25, 2021
    Applicant: TAEJOON PHARMACEUTICAL CO., LTD.
    Inventors: Joon Youb LEE, Woo Young JANG, Yiseul SONG
  • Patent number: 10905695
    Abstract: The present invention relates to an ophthalmic composition for lowering an intraocular pressure, the composition comprising latanoprost, polyoxyl 40 hydrogenated castor oil, and sorbitol.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: February 2, 2021
    Assignee: TAEJOON PHARMACEUTICAL CO., LTD.
    Inventors: Joon Youb Lee, Youn Jae Shin, Min Ji Lee